Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 2Phase 1 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 233Carcinoma, Non-Small-Cell Lung 132Breast Neoplasms 121Glioblastoma 88Ovarian Neoplasms 86Carcinoma, Hepatocellular 69Rectal Neoplasms 64Brain Neoplasms 57Lung Neoplasms 55Neoplasm Metastasis 54Neoplasms 52Colonic Neoplasms 50Fallopian Tube Neoplasms 43Glioma 40Carcinoma, Renal Cell 35Gliosarcoma 34Melanoma 26Adenocarcinoma of Lung 26Pancreatic Neoplasms 23Liver Neoplasms 23Uterine Cervical Neoplasms 21Stomach Neoplasms 21Recurrence 21Triple Negative Breast Neoplasms 18Kidney Neoplasms 16Endometrial Neoplasms 16Esophageal Neoplasms 15Astrocytoma 14Carcinoma, Ovarian Epithelial 13Adenocarcinoma, Bronchiolo-Alveolar 13

Interventions

Paclitaxel 4Oxaliplatin 4Cisplatin 4Radiotherapy 3Ocoxin 3Folfox protocol 3pembrolizumab 2camrelizumab 2apatinib 2anlotinib 2Sunitinib 2Sorafenib 2Imatinib Mesylate 2Gemcitabine 2Fluorouracil 2Drug Therapy 2Capecitabine 2Bevacizumab 2tislelizumab 1sintilimab 1regorafenib 1pyrotinib 1pemigatinib 1genexol-PM 1durvalumab 1donafenib 1copanlisib 1atezolizumab 1alectinib 1Tretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Digestive System Neoplasms × Bevacizumab × Clear all
NCT06096779 2026-05-04

Kirros

Genentech, Inc.

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT03271255 2019-01-23

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Shenzhen People's Hospital

Phase 2 Unknown
80 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡